Bacterial Infection | Norton Children's

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Bacterial Infection

An Open label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Subjects Less Than 18 Years of Age with Suspected or Confirmed Bacterial Infections

Sub-indication: Bacterial Infection

Study Type: Drug Study

Principal Investigator: Janice Sullivan, M.D.
Norton Children's Critical Care, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Melinta Therapeutics, Inc.

Learn more at ClinicalTrials.gov

Email for more information: NCRI-ID@NortonHealthcare.org

Search our entire site.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Bacterial Infection Clinical Trial